AP2007003939A0 - Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides - Google Patents

Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides

Info

Publication number
AP2007003939A0
AP2007003939A0 AP2007003939A AP2007003939A AP2007003939A0 AP 2007003939 A0 AP2007003939 A0 AP 2007003939A0 AP 2007003939 A AP2007003939 A AP 2007003939A AP 2007003939 A AP2007003939 A AP 2007003939A AP 2007003939 A0 AP2007003939 A0 AP 2007003939A0
Authority
AP
ARIPO
Prior art keywords
immunomodulator
glycerides
medium
fatty acids
chain length
Prior art date
Application number
AP2007003939A
Other languages
English (en)
Inventor
Lyne Gagnon
Christopher Penney
Boulos Zacharie
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of AP2007003939A0 publication Critical patent/AP2007003939A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2007003939A 2004-09-03 2005-09-02 Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides AP2007003939A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60691504P 2004-09-03 2004-09-03
PCT/CA2005/001343 WO2006024174A1 (en) 2004-09-03 2005-09-02 Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides

Publications (1)

Publication Number Publication Date
AP2007003939A0 true AP2007003939A0 (en) 2007-04-30

Family

ID=35999683

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003939A AP2007003939A0 (en) 2004-09-03 2005-09-02 Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides

Country Status (17)

Country Link
US (1) US20080090848A1 (xx)
EP (1) EP1784190A4 (xx)
JP (1) JP2008511553A (xx)
KR (1) KR20070063507A (xx)
CN (1) CN101080229A (xx)
AP (1) AP2007003939A0 (xx)
AU (1) AU2005279614A1 (xx)
BR (1) BRPI0515136A (xx)
CA (1) CA2578993A1 (xx)
EA (1) EA200700543A1 (xx)
IL (1) IL181684A0 (xx)
MA (1) MA28915B1 (xx)
MX (1) MX2007002727A (xx)
NO (1) NO20071413L (xx)
TN (1) TNSN07068A1 (xx)
WO (1) WO2006024174A1 (xx)
ZA (1) ZA200701781B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK12772003A3 (sk) * 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
DK1592416T3 (da) * 2003-02-07 2009-04-20 Prometic Biosciences Inc Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis
BRPI0919412A8 (pt) * 2008-09-19 2018-03-13 Inst Curie composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.
PE20100362A1 (es) * 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
WO2012102937A2 (en) * 2011-01-25 2012-08-02 Irm Llc Compounds that expand hematopoietic stem cells
WO2015183545A1 (en) 2014-05-28 2015-12-03 The Board Of Regents Of The University Of Texas System Novel compounds supports hematopoietic stem cells and red blood cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
US6071942A (en) * 1996-05-14 2000-06-06 Maxim Pharmaceuticals, Inc. Elevation of circulating blood histamine levels
SK12772003A3 (sk) * 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
DK1592416T3 (da) * 2003-02-07 2009-04-20 Prometic Biosciences Inc Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis

Also Published As

Publication number Publication date
BRPI0515136A (pt) 2008-07-08
EP1784190A4 (en) 2009-10-21
KR20070063507A (ko) 2007-06-19
WO2006024174A1 (en) 2006-03-09
US20080090848A1 (en) 2008-04-17
NO20071413L (no) 2007-05-30
ZA200701781B (en) 2008-11-26
TNSN07068A1 (en) 2008-06-02
EA200700543A1 (ru) 2007-10-26
JP2008511553A (ja) 2008-04-17
EP1784190A1 (en) 2007-05-16
MA28915B1 (fr) 2007-10-01
IL181684A0 (en) 2008-03-20
AU2005279614A1 (en) 2006-03-09
CN101080229A (zh) 2007-11-28
CA2578993A1 (en) 2006-03-09
MX2007002727A (es) 2008-03-04

Similar Documents

Publication Publication Date Title
ZA201003030B (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
EP1861087A4 (en) TREATMENT WITH STATINE AND OMEGA-3-FATTY ACID AS A COMBINATION PRODUCT THEREOF
EP1919468A4 (en) TREATMENT WITH CHOLESTEROL ABSORPTION INHIBITORS BASED ON AZETIDINONE AND OMEGA-3 FATTY ACID AND COMBINATION PRODUCT THEREOF
HK1106761A1 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
SI1592416T1 (sl) Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze
EP2089014A4 (en) OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT FOR REDUCING APO-B LEVELS
IL188163A0 (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
DK1773312T3 (da) Sammensætning omfattende statiner og omega-3-fedtsyrer
EP1685218A4 (en) Fatty acid esters and their use
EP2083815A4 (en) STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCING APO-B MIRRORS
EP1801096A4 (en) POLYGLYCERIN FUEL ACID AND THE COMPOSITIONS CONTAINING THEREOF
IL181684A0 (en) Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
HK1087007A1 (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity
ZA200807341B (en) Fatty acid by-products and methods of using same
ZA200807296B (en) Fatty acid by-products and methods of using same
IL177752A0 (en) Ester derivatives of rhein and their therapeutic use
EP2099295A4 (en) PROPHYLAXIS AND TREATMENT OF AURICULAR FIBRILLATION WITH OMEGA-3 FATTY ACIDS
ZA200800399B (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
HK1118804A1 (en) Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
PL378197A1 (pl) Pochodne kwasów indenokarboksylowych oraz ich zastosowanie do leczenia i zapobiegania cukrzycy i dyslipidemii
EP1765797A4 (en) PHENOTHIAZINE DERIVATIVES AND METHODS OF USE
HK1111358A1 (en) Medium-chain length fatty alcohols as stimulators of hematopoiesis
NO20043093D0 (no) Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils
ZA200702597B (en) Ester derivative and pharmaceutical use thereof